Table 1.
Patients and tumor characteristics.
| No | Sex | Age | KP | Tumor Location | CE | T/B | WHO Grade | Histology |
|---|---|---|---|---|---|---|---|---|
| 1 | M | 28 | 100 | Parietal, Temporal, Insular, L | Yes | Yes | IV | Glioblastoma |
| 2 | M | 58 | 90 | Temporal, R | Yes | Yes | IV | Glioblastoma |
| 3 | M | 64 | 80 | Frontal, L | Yes | Yes | IV | Glioblastoma |
| 4 | M | 52 | 80 | Frontal, R | Yes | Yes | IV | Glioblastoma |
| 5 | M | 62 | 80 | Occipital, CC, L | Yes | Yes | IV | Glioblastoma |
| 6 | M | 67 | 90 | Temporal, Insular, R | Yes | Yes | IV | Glioblastoma |
| 7 | M | 56 | 70 | Occipital, CC, Temporal, L | Yes | Yes | IV | Glioblastoma |
| 8 | M | 63 | 90 | Frontal, L | Yes | Yes | IV | Glioblastoma |
| 9 | F | 71 | 70 | Parietal, Occipital, R | Yes | Yes | IV | Glioblastoma |
| 10 | M | 46 | 80 | Frontal, CC, R, L | Yes | Yes | IV | Glioblastoma |
| 11 | M | 51 | 100 | Temporal, Insular, R | No | No | III | Oligoastrocytoma |
| 12 | M | 58 | 90 | Hemisphere, R, Brain-stem | Yes | No | III | Gliomatosis |
| 13 | M | 54 | 100 | Frontal, R | No | No | II | Oligodendroglioma |
M: Male, F: Female, KP: Karnofsky’s performance scale, R: Right, L: Left, CC: Corpus callosum. CE: Contrast enhancement after Gadolinium, T/B: Tissue to blood ratio ≥1.2, WHO: World Health Organization.